Taylor Financial Group
MIST icon

Taylor Financial Group’s Milestone Pharmaceuticals MIST Stock Holding History

Taylor Financial Group’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$17.3K Hold
20,000
– – 0.01% 96
2026
Q2 		$26.8K Buy
20,000
+5,000
+33% +$7.99K 0.01% 103
2026
Q1 		$17.8K Buy
15,000
+5,000
+50% +$8.75K 0.01% 99
2025
Q4 		$20.2K Hold
10,000
– – 0.01% 102
2025
Q3 		$20K Hold
10,000
– – 0.01% 105
2025
Q2 		$19.4K Buy
+10,000
New +$13.3K 0.01% 104

Other funds holding MIST

Pavaki Capital Management
Pavaki Capital Management Pueblo, Colorado $294M AUM 34.46% 1-Year Est. Return
Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
RVW Wealth
RVW Wealth Los Angeles, California $1.56B AUM 16.49% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Valeo Financial Advisors
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.14% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
October Effect
October Effect Virginia Beach, Virginia $98.3M AUM 66.25% 1-Year Est. Return
Welch & Forbes
Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return
Stephenson & Company
Stephenson & Company San Clemente, California $220M AUM 8.29% 1-Year Est. Return
Strategic Family Wealth Counselors
Strategic Family Wealth Counselors Fairfield, New Jersey $429M AUM 8.84% 1-Year Est. Return

Taylor Financial Group's MIST Position: Q3 2026 in Review

Taylor Financial Group held its Milestone Pharmaceuticals (MIST) position steady in Q3 2026 at 20,000 shares worth $17.3K. The position accounts for 0.01% of the portfolio, ranked #96.

Taylor Financial Group first reported a position in MIST in Q2 2025 and has held it in 6 quarters since. The position peaked at $26.8K in Q2 2026. 23 funds tracked by Wall St. Rank hold MIST as of Q3 2026.

  • Taylor Financial Group held 20,000 shares of Milestone Pharmaceuticals worth $17.3K as of Q3 2026.
  • Taylor Financial Group left its Milestone Pharmaceuticals share count unchanged in Q3 2026.
  • Milestone Pharmaceuticals made up 0.01% of Taylor Financial Group's portfolio in Q3 2026, its #96 holding.
  • Taylor Financial Group first reported a position in Milestone Pharmaceuticals in Q2 2025 and has held it in 6 quarters since.
  • Taylor Financial Group's Milestone Pharmaceuticals position peaked at $26.8K in Q2 2026.
  • 23 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q3 2026.

Based on Taylor Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.